Drug-Associated Risk of Subacute Cutaneous Lupus Erythematosus: A Pharmacovigilance Study of the FDA Adverse Event Reporting System

J Cutan Med Surg. 2024 Dec 21:12034754241303082. doi: 10.1177/12034754241303082. Online ahead of print.

Authors

Liu Yang¹, Han-Zhang Xie², Yi-Xuan Yang¹, Bing-Nan Cui¹, Zhan-Shuo Xiao¹

Affiliations

¹ Department of Dermatology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
² College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

PMID: 39708303
DOI: 10.1177/12034754241303082

No abstract available

Keywords: FAERS; adverse event; pharmacovigilance; real world; subacute cutaneous lupus erythematosus.

Publication types

Letter